Industry News

Baxter Completes Acquisition of Hemostat and Sealant Products from Mallinckrodt plc.

Published on 2018-03-26. Author : SpecialChem

TAGS:  Sealants    

Baxter Acquires Mallinckrodt Products
Baxter International Inc. has announced that it has completed the acquisition of two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin topical (Recombinant) is the first and only stand-alone recombinant thrombin and PREVELEAK Surgical Sealant is used in vascular reconstruction.

Expansion of Surgical Hemostat and Sealant Portfolio

Both products Recothrom & Preveleak complement and broaden Baxter’s existing surgical portfolio of hemostats and sealants.

  • With RECOTHROM, Baxter can now provide surgeons with additional options of innovative hemostatic products to handle different severities of bleeding.
  • PREVELEAK complements its existing portfolio of advanced surgical sealants.

Baxter Acquiring 2 Products

The acquisition deal is expected to be modestly accretive to Baxter’s 2018 adjusted earnings and increasingly accretive thereafter.

Under the terms of the agreement, Baxter is acquiring RECOTHROM and PREVELEAK for an upfront payment of approximately $153 million and potential contingent payments in the future.

Wil Boren, president of Baxter’s Advanced Surgery business, said:

We are excited to add both RECOTHROM and PREVELEAK to our portfolio of hemostats and sealants to offer surgeons additional options that address different situations when intraoperative bleeding can occur. Our top priority right now is working with customers and distributors to ensure a smooth transition.”

Source: Baxter
Improve your performance with water soluble epoxy compounds
Naphthenic Oils For Better Adhesion
Channel Alerts

Receive weekly digests on hot topics

Back to Top